BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19954622)

  • 1. [Severe hypercalcemia complicated in acute lymphoblastic leukemia (ALL) with E2A-HLF fusion gene: report of two cases and literature review].
    Yang J; Zhou X; Wang B; Gao C; Zhang RD; Li B
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):615-8. PubMed ID: 19954622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
    Inukai T; Hirose K; Inaba T; Kurosawa H; Hama A; Inada H; Chin M; Nagatoshi Y; Ohtsuka Y; Oda M; Goto H; Endo M; Morimoto A; Imaizumi M; Kawamura N; Miyajima Y; Ohtake M; Miyaji R; Saito M; Tawa A; Yanai F; Goi K; Nakazawa S; Sugita K
    Leukemia; 2007 Feb; 21(2):288-96. PubMed ID: 17183364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J; O'Sullivan E; Hubank M; Brady HJ
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
    Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
    Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
    Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
    He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
    Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
    Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia in acute lymphoblastic leukemia: an overview.
    Trehan A; Cheetham T; Bailey S
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):424-7. PubMed ID: 19648791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP; Ohyashiki K; Toyama K; Cleary ML
    Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
    de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
    Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful preemptive donor lymphocyte infusions from a haploidentical donor in a boy with E2A-HLF-positive ALL.
    Hirai M; Yagasaki H; Fujimura J; Inoue M; Shimozawa K; Okuma H; Chin M; Takahashi S
    Leuk Lymphoma; 2018 Mar; 59(3):746-748. PubMed ID: 28728518
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP; Brown R; Cleary ML
    Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
    Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
    Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
    Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias.
    Mitani K; Sasaki K; Ogawa S; Hayashi Y; Mano H; Yazaki Y; Hirai H
    Int J Hematol; 1994 Dec; 60(4):267-71. PubMed ID: 7894030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
    Akahane K; Inukai T; Inaba T; Kurosawa H; Look AT; Kiyokawa N; Fujimoto J; Goto H; Endo M; Zhang X; Hirose K; Kuroda I; Honna H; Kagami K; Goi K; Nakazawa S; Sugita K
    Leukemia; 2010 Apr; 24(4):865-9. PubMed ID: 20147975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.